全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

血压难控因素的中医认识及辨治体会

Keywords: 经方,高血压病,血压难控因素,中医药治疗

Full-Text   Cite this paper   Add to My Lib

Abstract:

高血压是心脑血管疾病最主要的危险因素,已成为全球重大公共卫生问题。控制血压可以大大减少或延缓并发症的出现,减少心脑血管风险的发生。然而,临床上依然存在即使增加降压药物的种类和剂量,降压疗效依然不佳的现象。究其原因,除常见的药物因素、饮食因素、运动因素等之外,常可找到严重干扰降压的诱因,即“血压难控因素”。近年来,血压难控因素备受关注,包括失眠、便秘、情绪、外感等。临床发现,诱因一旦找到,给予恰当的辨证论治,血压往往能迅速下降,降压药物的种类和剂量也随之减少。近年来,“血压难控因素”的防治逐渐受到业内关注,这与当前对高血压病的认识不谋而合因此,高血压病的防治策略不应仅仅着眼于“患者的高血压”本身,而应更加关注“高血压的患者”。加强对“血压难控因素”的认识及治疗,可能正是中医药治疗高血压病的优势所在。

References

[1]  Fisher J W. The diagnostic value of the sphygmomanometer in examinations for life insurance [J]. J Amer Med Assoc,1914,63: 1752.
[2]  Sliwa K, Stewart S, Gersh B J. Hypertension: a global perspective [J]. Circulation,2011,123: 2892.
[3]  Silva A P, Moreira C, Bicho M, et al. Nocturnal sleep quality and circadian blood pressure variation[J]. Rev Port Cardiol,2000, 19 (10): 991.
[4]  Meng L, Zheng Y, Hui R T. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies[J]. Hyperten Res, 2013,doi: 10.1038/hr.2013.70.
[5]  Grandner M A, Perlis M L. Short sleep duration and insomnia associated with hypertension incidence[J]. Hyperten Res, 2013,doi:10.1038/hr.2013.83.
[6]  Lusardi P, Zoppi A, Preti P, et al. Effects of insufficient sleep on blood pressure in hypertensive patients: A 24-h study [J]. Am J Hypertens,1999,12: 63.
[7]  Ishikaway U R, Nakayama T. Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious cdts [J]. Biochem Biophys Res Commun,1982,109 (2): 576.
[8]  熊兴江,何庆勇,汤艳莉,等.经方方证运用体悟[J].上海中医药杂志,2009,43(2):15.
[9]  熊兴江,李海霞.柴胡加龙骨牡蛎汤证运用体悟[J].上海中医药杂志,2010,44(10):22.
[10]  王阶,熊兴江,何庆勇,等.方证对应内涵及原则探讨[J].中医杂志,2009,50(3):197.
[11]  Wang J, Feng B, Yang X C, et al. Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/706125.
[12]  Xiong X J, Yang X C, Feng B, et al. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/982380.
[13]  Wang J, Yang X C, Feng B, et al. Is Yangxue Qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension [J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/540613.
[14]  熊兴江,王阶,王师菡,等.方证对应理论研究概况[J].中华中医药杂志,2009,24(12):1624.
[15]  Spinzi G, Amato A, Imperiali G, et al. Constipation in the elderly: management strategies [J]. Drug Aging, 2009,26: 469.
[16]  Choung R S, Locke G R, Schleck C D, et al. Cumulative incidence of chronic constipation: a population based study 1988—2003 [J]. Aliment Pharmacol Ther,2007,26: 1521.
[17]  Xiong X J, Yang X C, Liu W, et al. Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med,2012,doi: 10.1155/2012/271462.
[18]  熊兴江,王阶.论半夏白术天麻汤在高血压病中的运用[J].中华中医药杂志,2012,27(11):2862.
[19]  Wang J, Yao K W, Yang X C, et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med,2012,doi: 10.1155/2012/714805.
[20]  Wang J, Xiong X J, Yang G Y, et al. Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/262685.
[21]  Rutledge T, Hogan B E. A quantitative review of prospective evidence linking psychological factors with hypertension development [J]. Psychosom Med,2002,64: 758.
[22]  Rozanski A, Blumenthal J A, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy[J]. Circulation,1999,99: 2192.
[23]  Davidson K, Jonas B S, Dixon K E, et al. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study. Coronary risk development in young adults[J]. Arch Intern Med,2000, 160: 1495.
[24]  Markovitz J H, Jonas B S, Davidson K. Psychologic factors as precursors to hypetension[J]. Curr Hypertens Rep, 2001, 3: 25.
[25]  Empana J P, Jouven X, Lemaitre R N, et al. Clinical depression and risk of out of hospital cardiac arrest[J]. Arch Intern Med, 2006, 166: 195.
[26]  Scalco A Z, Scalco M Z, Azul J B, et al. Hypertension and depression[J]. Clinics, 2005,60: 241.
[27]  Levenstein S, Smith M W, Kaplan G A. Psychosocial predictors of hypertension in men and women[J]. Arch Intern Med, 2001, 161: 1341.
[28]  Diekens C, Gowan L, Percival C, et al. New onset depression following myocardical infarction predicts cardiac mortality[J]. Psychosom Med, 2008, 70: 450.
[29]  熊兴江,李海霞.柴胡类方方证运用体悟[J].世界中西医结合杂志,2011,6(3):238.
[30]  熊兴江,王朋倩.《伤寒论》表里同病之临证体悟[J].中国中医急症,2010,19(1):146.
[31]  Wang J, Wang P Q, Xiong X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine [J]. Int Med, 2012,2: 1.
[32]  熊兴江,王阶.名医经验传承探索之路[J].中医杂志,2011,52(7):545.
[33]  Mancia G, Backer G D, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) [J]. J Hypertens,2007, 25: 1105.
[34]  Kearney P M, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data [J]. Lancet,2005,365: 217.
[35]  Chobanian A V, Bakris G L, Black H R, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure [J]. Hypertension,2003,42: 1206.
[36]  Whelton P K, He J, Appel L J, et al. Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program [J]. J Amer Med Assoc,2002,288: 1882.
[37]  Xiong X J, Yang X C, Liu W, et al. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine [J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/275279.
[38]  熊兴江,王阶.论高血压病的中医认识及经典名方防治策略[J].中医杂志,2011,52(23):1985.
[39]  唐补生,曹敏,李广浩,等.血压难控因素的中医辨识和治疗[J].辽宁中医杂志,2009,36(2):197.
[40]  Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine[J]. Evid Based Complement Alternat Med, 2012, doi: 10.1155/2012/284847.
[41]  熊兴江,王阶.经方在高血压病治疗中的运用[J].中国中药杂志,2013,38(11):1836.
[42]  Xiong X J, Yang X C, Liu Y M, et al. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science [J]. Hyperten Res, 2013,36: 570.
[43]  Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China[J]. Evid Based Complement Alternat Med, 2012, doi: 10.1155/2012/268542.
[44]  Wang J, Xiong X J. Evidence-based Chinese medicine for hypertension[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/978398.
[45]  Wang J, Xiong X J. Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews [J]. Evid Based Complement Alternat Med, 2012, doi: 10.1155/2012/697237.
[46]  Wang J, Feng B, Yang X C,et al. Chinese herbal medicine for the treatment of prehypertension[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/493521.
[47]  Wang J, Feng B, Xiong X J. Chinese herbal medicine for the treatment of obesity-related hypertension[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/757540.
[48]  熊兴江,王阶.外感高热诊疗心悟[J].中西医结合学报,2011,9(6):681.
[49]  Xiong X J, Chu F Y, Li H X, et al. Clinical application of the TCM classic formulae for treating chronic bronchitis [J]. J Tradit Chin Med,2011,31 (1): 69.
[50]  Wang J, Feng B, Yang X C,et al. Tai Chi for essential hypertension[J]. Evid Based Complement Alternat Med, 2013, doi: 10.1155/2013/215254.
[51]  Xiong X J, Liu W, Yang X C, et al. Moxibustion for essential hypertension[J]. Complement Therapies Med, 2013, doi:org/10.1016/j.ctim.2013.11.005.
[52]  Brook R D, Appel L J, Rubenfire M, et al. On behalf of the American heart association professional education committee of the council for high blood pressure research, council on cardiovascular and stroke nursing, council on epidemiology and prevention, and council on nutrition, physical activity and metabolism. Beyond medications and diet: alternative approaches to lowering blood pressure[J]. Hypertension,2013, 61: 1360.
[53]  熊兴江.补肾降压理论及补肾降压方对自发性高血压大鼠miR-1调控心室肥厚ERK通路的影响[D].北京:中国中医科学院,2013.
[54]  熊兴江,王阶.基于药物客观指征的《方剂学》相关问题[J].中西医结合学报,2010,8(1):20.
[55]  熊兴江.方证对应史研究[J].中西医结合学报,2010,8(6):581.
[56]  王阶,熊兴江.病机用药与方证用药辨析[J].中医杂志,2009,50(9):777.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133